Tag: trenibotulinumtoxinE

All

Allergan Aesthetics Presents New Data on Facial Injectable Portfolio at IMCAS 2026

Nine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.

Allergan Aesthetics Presents Data on Investigational Neurotoxin and GLP-1 Patient Trends
FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Toxin Application
Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines
Allergan Wins First Approval for Short-Acting Neurotoxin in Canada

All

Sorry, No Posts Found

All

The Aesthetic Society Honors Dr Jeffrey Spiegel with Lifetime Achievement Award

The award recognizes over two decades of contributions to research, innovation, and education in the field of aesthetic medicine.

Sorry, No Posts Found